Alex Craven

Phytome Life Sciences Ltd. operates as a biopharmaceutical research company. It is engaged in the research & development of plant-based medicinal products and the pharmaceutical development of novel phytochemicals. The firm develops technologies in pharmaceutical agriculture, process chemistry and screening technologies to access plant-based compounds & novel molecules, with an initial focus on medical cannabis. The company was founded on June 4, 2018 and is headquartered in London, the United Kingdom.

Phytome Life Sciences Ltd. operates as a biopharmaceutical research company. It is engaged in the research & development of plant-based medicinal products and the pharmaceutical development of novel phytochemicals. The firm develops technologies in pharmaceutical agriculture, process chemistry and screening technologies to access plant-based compounds & novel molecules, with an initial focus on medical cannabis. The company was founded on June 4, 2018 and is headquartered in London, the United Kingdom.

Phytome Life Sciences Ltd. operates as a biopharmaceutical research company. It is engaged in the research & development of plant-based medicinal products and the pharmaceutical development of novel phytochemicals. The firm develops technologies in pharmaceutical agriculture, process chemistry and screening technologies to access plant-based compounds & novel molecules, with an initial focus on medical cannabis. The company was founded on June 4, 2018 and is headquartered in London, the United Kingdom.

Phytome Life Sciences Ltd. operates as a biopharmaceutical research company. It is engaged in the research & development of plant-based medicinal products and the pharmaceutical development of novel phytochemicals. The firm develops technologies in pharmaceutical agriculture, process chemistry and screening technologies to access plant-based compounds & novel molecules, with an initial focus on medical cannabis. The company was founded on June 4, 2018 and is headquartered in London, the United Kingdom.

Phytome Life Sciences Ltd. operates as a biopharmaceutical research company. It is engaged in the research & development of plant-based medicinal products and the pharmaceutical development of novel phytochemicals. The firm develops technologies in pharmaceutical agriculture, process chemistry and screening technologies to access plant-based compounds & novel molecules, with an initial focus on medical cannabis. The company was founded on June 4, 2018 and is headquartered in London, the United Kingdom.